In silico pharmacology

In Silico Pharmacol · ISSN (print) 2193-9616 · 2 papers in corpus

article 2026

In silico evaluation of procyanidin as a potential ESR1 inhibitor: docking and MD insights in uterine fibroids and endometriosis

doi:10.1007/s40203-025-00541-z ·PMID:41552640

These are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age diseases. The existing treatments, such as hormonal drugs and selective estrogen receptor modulators like raloxifene, have side effects…

other 2025

Network pharmacology prediction of UA in targeting endometriosis progression to endometrial cancer

doi:10.1007/s40203-025-00492-5 ·PMID:41322714

UNLABELLED: Endometriosis is a gynecological disorder predominantly affecting women of reproductive age and is considered a potential risk factor for the development of endometrial cancer. However, the molecular mechanisms underlying the tr…